BREAKTHROUGH GENE THERAPY FOR ANXIETY TREATMENT
With more than 30 percent of Americans experiencing anxiety disorders at some point in their lives--and with treatment costs continuing to rise--there is growing demand for innovative solutions that address anxiety at its biological roots.
In
Brain Medicine, neuroscientist Troy Rohn, PhD, presents a bold and hopeful vision for the future of anxiety treatment. Blending cutting-edge neurological research with his own lived experience struggling with anxiety, Dr. Rohn introduces a first-of-its-kind therapeutic approach aimed at treating anxiety with unprecedented molecular precision. By targeting a key serotonin receptor through advanced gene-based techniques, he explores a promising new pathway for addressing chronic anxiety and related memory challenges.
Inside
Brain Medicine, you will discover:
- The emerging potential of genetic therapies to transform anxiety treatment
- How DNA editing technologies may one day be applied to mental health
- A forward-looking exploration of the future of neuroscience and psychiatry
- The complex journey from early-stage laboratory research to clinical application
- Key ethical considerations driving innovation in mental health care
Whether you're a clinician looking for the latest scientific advancements or an individual seeking deeper understanding of chronic anxiety,
Brain Medicine offers clear, insightful, and compassionate guidance. It's time to rethink how we treat anxiety--starting at its source.
Troy Rohn, PhD, has built a substantial academic reputation with nearly three decades of experience in neuroscience research and teaching. For his contributions to Alzheimer's research and neurological disorders, he was recently recognized as one of the top 0.5% of scholars worldwide. Dr. Rohn received his Ph.D. in Pharmacology from the University of Washington, Seattle. He had several Postdoctoral stints including 2+ years living in France, a year at Montana State University, and 2 years at UC Irvine. He has obtained extramural funding continuously since his arrival at Boise State University (where he currently works as a professor in the Biology Department) including grants from NIH, AFAR, and AHAF. Dr. Rohn has authored over 80 peer-reviewed publications, many of which address topics related to neurobiology, mental health, and treatment strategies.
Dr. Dean Radin currently serves as Chief Scientist at the Institute of Noetic Sciences (IONS) and Associated Distinguished Professor at the California Institute of Integral Studies. His academic background includes a PhD in psychology from the University of Illinois, Urbana-Champaign. Before joining IONS in 2001, he worked on advanced research and development at AT&T Bell Labs and GTE Laboratories. With Dr. Rohn, Dr. Radin is the co-founder and Vice Chairman of Cognigenics, a research group working to pioneer non-invasive genetic medicine for the brain. He is also the author/co-author of hundreds of articles and several popular books, including
The Conscious Universe and
Entangled Minds.
